Biomarkers in Immuno-Oncology: Sorting through the Noise & Confusion


In this study, HRA® explores this paradigm shift in the use of immunotherapy:

  • Learn the current awareness and use of biomarkers
  • Uncover the relevance of biomarkers to your patient population and the available treatment options
  • Get a clear road map of biomarker application and use in diagnosis and treatment choice
  • Hear from key thought leaders to understand industry impact


  • Executive Summary
  • Community Oncologist Profile
  • Drugs in Development, by Key Metrics
  • Immunotherapy Landscape Insights

Find syndicated research too general? Tailor our findings to your needs!

  • Use this as a start to follow-up custom research
  • Custom reporting and analysis focused on your team’s issues
Price: $5,000.00
Copyright HRA Data Driven Intelligence 1974-2020 HRA Data Driven Intelligence, LLC. All rights Reserved.